Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

Abstract

Gliomas are associated with high mortality because of their exceedingly invasive character. As these tumors acquire their invasiveness from low-grade tumors, it is very important to understand the detailed molecular mechanisms of invasion onset. Recent evidences suggest the significant role of microRNAs in tumor invasion. Thus, we hypothesized that deregulation of microRNAs may be important for the malignant progression of gliomas. We found that the aberrant expression of miR-21 is responsible for glioma invasion by disrupting the negative feedback circuit of Ras/MAPK signaling, which is mediated by Spry2. Upregulation of miR-21 was triggered by tumor microenvironmental factors such as hyaluronan and growth factors in glioma cells lacking functional phosphatase and tensin homolog (PTEN), but not harboring wild-type PTEN. Consistently with these in vitro results, Spry2 protein levels were significantly decreased in 79.7% of invasive WHO grade II–IV human glioma tissues, but not in non-invasive grade I and normal tissues. The Spry2 protein levels were not correlated with their mRNA levels, but inversely correlated with miR-21 levels. Taken together, these results suggest that the post-transcriptional regulation of Spry2 by miR-21 has an essential role on the malignant progression of human gliomas. Thus, Spry2 may be a novel therapeutic target for treating gliomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Cabrita MA, Christofori G . (2008). Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11: 53–62.

    Article  CAS  Google Scholar 

  • Chan JA, Krichevsky AM, Kosik KS . (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029–6033.

    Article  CAS  Google Scholar 

  • Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, Angileri FF et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93: 325–332.

    Article  CAS  Google Scholar 

  • Croce CM . (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704–714.

    Article  CAS  Google Scholar 

  • Friedman RC, Farh KK, Burge CB, Bartel DP . (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92–105.

    Article  CAS  Google Scholar 

  • Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A et al. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683–2710.

    Article  CAS  Google Scholar 

  • Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369–5380.

    Article  CAS  Google Scholar 

  • Hirschhorn JN . (2009). Genomewide association studies--illuminating biologic pathways. N Engl J Med 360: 1699–1701.

    Article  CAS  Google Scholar 

  • Kim MS, Kwak HJ, Lee JW, Kim HJ, Park MJ, Park JB et al. (2008). 17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion. Mol Cancer Res 6: 1657–1665.

    Article  CAS  Google Scholar 

  • Kim MS, Park MJ, Kim SJ, Lee CH, Yoo H, Shin SH et al. (2005). Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int J Oncol 27: 839–846.

    CAS  PubMed  Google Scholar 

  • Kim VN, Nam JW . (2006). Genomics of microRNA. Trends Genet 22: 165–173.

    Article  CAS  Google Scholar 

  • Krichevsky AM, Gabriely G . (2009). miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39–53.

    Article  CAS  Google Scholar 

  • Lo TL, Fong CW, Yusoff P, McKie AB, Chua MS, Leung HY et al. (2006). Sprouty and cancer: the first terms report. Cancer Lett 242: 141–150.

    Article  CAS  Google Scholar 

  • Merzak A, Koocheckpour S, Pilkington GJ . (1994). CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988–3992.

    CAS  PubMed  Google Scholar 

  • National Cancer Institute (2005). REMBRANDT home page. http://rembrandt.nci.nih.gov. Accessed 29 September 2009.

  • Negrini M, Nicoloso MS, Calin GA . (2009). MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol 21: 470–479.

    Article  CAS  Google Scholar 

  • Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA . (2009). MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293–302.

    Article  CAS  Google Scholar 

  • Park JB, Kwak HJ, Lee SH . (2008). Role of hyaluronan in glioma invasion. Cell Adh Migr 2: 202–207.

    Article  Google Scholar 

  • Park MJ, Kim MS, Park IC, Kang HS, Yoo H, Park SH et al. (2002). PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 62: 6318–6322.

    CAS  Google Scholar 

  • Roversi G, Pfundt R, Moroni RF, Magnani I, Van Reijmersdal S, Pollo B et al. (2006). Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines. Oncogene 25: 1571–1583.

    Article  CAS  Google Scholar 

  • Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H et al. (2008). MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19: 3272–3282.

    Article  CAS  Google Scholar 

  • Shaw AT, Meissner A, Dowdle JA, Crowley D, Magendantz M, Ouyang C et al. (2007). Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev 21: 694–707.

    Article  CAS  Google Scholar 

  • TCGARN (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061–1068.

    Article  Google Scholar 

  • Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980–984.

    Article  CAS  Google Scholar 

  • Toole BP . (2004). Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528–539.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Cancer Center Grants (1010171, 1010172, and 1110120) and the National Research Foundation Grant (2010-0016811). JHK was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2010-0016704).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J B Park or S-H Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kwak, HJ., Kim, YJ., Chun, KR. et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30, 2433–2442 (2011). https://doi.org/10.1038/onc.2010.620

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.620

Keywords

This article is cited by

Search

Quick links